Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 9 February 2023.

Powered by Capital Market - Live News

KIMS, through its subsidiary Sarvejana Healthcare, held 100% stake in Suryateja Healthcare.

The company has has disinvested its entire stake in Suryateja Healthcare in favour of group of doctors - Dr. Karampudi Kamalakar, Dr. Nalamaru Vamsi, Dr. Suresh Kumar Thatipamula, Ms. Divya Puskur, and Dr. Omprakash Tumma (collectively to be called as 'purchaser) - under an agreement to takeover company by transfer of shares.

The purchasers paid a total composite consideration of Rs 2.50 crore.

Suryateja Healthcare had recorded a total income of Rs 16.45 crore and its net worth was Rs (2.17) crore. It had became a step-down subsidiary of KIMS w.e.f 01 April, 2022, hence no consolidation effect arise in P.Y, the company said.

Headquartered in Hyderabad, KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. It has a network of 13 hospitals and 4000 beds spread across Telangana, Andhra Pradesh and Maharashtra.

The company's consolidated net profit rose 18.8% to Rs 97.11 crore on a 37% rise in sales to Rs 564.07 crore in Q2 FY23 over Q2 FY22.

Shares of KIMS fell 0.51% to end at Rs 1500.80 on Friday, 14 January 2023.

Powered by Capital Market - Live News

Krishna Institute of Medical Sciences announced that Suryateja Healthcare, a step-down subsidiary of the Company, in which the Company, indirectly through its subsidiary i.e Sarvejana Healthcare holds 100% holding has disinvested its entire stake in favour of group of doctors [Dr. Karampudi Kamalakar, Dr. Nalamaru Vamsi, Dr. Suresh Kumar Thatipamula, Divya Puskur, and Dr. Omprakash Tumma (collectively to be called as “Purchaser”)] under an agreement to takeover company by transfer of shares.

Powered by Capital Market - Live News

The Board of Krishna Institute of Medical Sciences at its meeting held on 04 January 2023 has approved the raising of funds by way of issuance of Non-Convertible Debentures (NCDs) aggregating to Rs. 300 crore in one or more tranches over a period of time, subject to the shareholders' approval.

Powered by Capital Market - Live News